MCMCB Pro
J0675

J0675Injection, carboprost tromethamine, 0.1 mg

HCPCSActiveBETOS O1E

J0675 is a HCPCS Level II code for injection, carboprost tromethamine, 0.1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for J0675

Long descriptor
Injection, carboprost tromethamine, 0.1 mg

The official wording. This is what the code means.

Short descriptor
Inj, carboprost, 0.1 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2025

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J0675

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0675 is not quite right, the correct code is very often within a few positions of it.

  • J0650Injection, levothyroxine sodium, not otherwise specified, 10 mcg
  • J0651Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
  • J0652Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
  • J0654Injection, liothyronine, 1 mcg
  • J0665Injection, bupivicaine, not otherwise specified, 0.5 mg
  • J0666Injection, bupivacaine liposome, 1 mg
  • J0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
  • J0670Injection, mepivacaine hydrochloride, per 10 ml
  • J0681Injection, ceftobiprole medocaril sodium, 3 mg
  • J0687Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
  • J0688Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg
  • J0689Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
  • J0690Injection, cefazolin sodium, 500 mg
  • J0691Injection, lefamulin, 1 mg
  • J0692Injection, cefepime hydrochloride, 500 mg
  • J0693Injection, cefiderocol, 5 mgterminated

Questions about J0675

What is HCPCS code J0675?

J0675 is a HCPCS Level II code for injection, carboprost tromethamine, 0.1 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J0675?

The CMS HCPCS file marks J0675 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J0675 paid under the physician fee schedule?

J0675 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026